How does reputation management work for medical device companies?

Medical device companies sell to a clinical audience under FDA constraints, so reputation work is built around evidence and compliance rather than persuasion. Content must be FDA-compliant, which sharply limits claims and requires that efficacy and safety be framed in clinical-evidence terms rather than marketing language. The primary audience is physicians and procurement committees, who weigh peer-reviewed evidence and authoritative third-party coverage far more than promotional material, so the work emphasizes credible, citable signals. The AI layer is where new risk concentrates: patients and clinicians now ask AI engines about device safety and efficacy, and misinformation – from adverse-event chatter to litigation coverage – gets synthesized into confident answers quickly. We monitor those safety and efficacy prompts across the AI engines with AIQ™, because a model that summarizes a device unfavorably or inaccurately can affect clinical adoption and procurement, and in this sector that correction has to be both fast and scrupulously compliant.